6/4
04:05 pm
prpl
Purple to Participate in Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
Medium
Report
Purple to Participate in Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
5/8
12:29 pm
prpl
Purple Innovation, Inc. (NASDAQ:PRPL) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Purple Innovation, Inc. (NASDAQ:PRPL) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
11:54 am
prpl
Purple Innovation, Inc. (NASDAQ: PRPL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $2.25 price target on the stock.
Low
Report
Purple Innovation, Inc. (NASDAQ: PRPL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $2.25 price target on the stock.
5/7
07:13 pm
prpl
Purple Innovation (PRPL) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
Low
Report
Purple Innovation (PRPL) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
5/7
04:19 pm
prpl
Purple Innovation Reports First Quarter 2024 Results [Yahoo! Finance]
Low
Report
Purple Innovation Reports First Quarter 2024 Results [Yahoo! Finance]
5/7
04:05 pm
prpl
Purple Innovation Reports First Quarter 2024 Results
Medium
Report
Purple Innovation Reports First Quarter 2024 Results
4/30
04:25 pm
prpl
Purple to Report First Quarter 2024 Results on May 7, 2024 [Yahoo! Finance]
Low
Report
Purple to Report First Quarter 2024 Results on May 7, 2024 [Yahoo! Finance]
4/30
04:05 pm
prpl
Purple to Report First Quarter 2024 Results on May 7, 2024
Low
Report
Purple to Report First Quarter 2024 Results on May 7, 2024
4/11
10:37 am
prpl
Fast-paced Momentum Stock Purple Innovation (PRPL) Is Still Trading at a Bargain [Yahoo! Finance]
Low
Report
Fast-paced Momentum Stock Purple Innovation (PRPL) Is Still Trading at a Bargain [Yahoo! Finance]
3/21
10:45 am
prpl
Purple Innovation, Inc. (NASDAQ: PRPL) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $2.50 price target on the stock.
Low
Report
Purple Innovation, Inc. (NASDAQ: PRPL) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $2.50 price target on the stock.